Stay updated with breaking news from மித்ரா உயிர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology. Key suggestions from the report: The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines ....
Biotechnology Market Size Worth $2.44 Trillion By 2028 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Image by Viacheslav Iakobchuk - Adobe Stock Illumina has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the United States and the United Kingdom. Unlocking the power of the human genome is a feat that no one organization can fully accomplish on its own. That s why, back in 2014, Illumina created the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Now in its sixth year, the Illumina Accelerator has just selected nine new genomics companies to join its latest funding cycle four companies for the accelerator s Cambridge, England location, and five companies for the San Francisco Bay Area location. The Illumina Accelerator has helped create a total of 54 genomics companies including the nine that were just announced. ....
San Diego-based life sciences equipment giant Illumina said today that it has made investments in nine new genomics companies, as part of the company s startup accelerator, the Illumina Accelerator. ....